MediWales
9 News & Press Releases found

MediWales news

The University of South Wales (USW) is celebrating another year of success in supporting student and graduate entrepreneurs through a range of enterprise programmes and the expansion of its graduate incubators to all of its three campuses.

This agenda has been actively supported not only through additional funding from USW but by ongoing investment in this agenda from both the Welsh Government and the Higher Education Funding Council for Wa

Jun. 16, 2022

R&D biotechnology company Midatech Pharma has revealed changes to its board, following its chairman announcing his intention to retire.

Rolf Stahel will step down from the board on 20 June 2022 and it is expected that Stephen Parker will be appointed as non-executive chairman, following the AGM.

Parker will join the Cardiff-based company, which works on improving the bio-delivery and biodistribution of medicines, with more than 30 years’ e

Jun. 12, 2022

EKF Diagnostics Holdings has launched its latest product as it looks to identify new opportunities.

EKF Link is a digital connectivity service for the secure management of point-of-care (POC) analysers and associated data on one platform.

It is designed to enable the real-time remote management of data, such as patient test results, quality control, calibration results, operator management and analyser configuration, and is geared towards hospitals,

Jun. 9, 2022

Targeted intervention measures for Betsi Cadwaladr University Health Board will be extended to include services at Ysbyty Glan Clwyd, the Health Minister Eluned Morgan has announced today.

The decision, made following a tripartite meeting as part of the NHS Wales Escalation Framework, follows ongoing concerns relating to the health board in a number of areas.

Health Minister Eluned Morgan said:

Jun. 6, 2022

Patients with incurable breast cancer could potentially benefit from new Welsh-led research, latest evidence suggests.

The research, carried out by Velindre University NHS Trust, in partnership with AstraZeneca and Cardiff University over 10 years was presented at the world renowned American Society of Clinical Oncology conference on 4 June in Chicago and published simultaneously in the prestigious 

Jun. 6, 2022